Navigation Links
Childhood vaccination may protect adult eyes
Date:9/19/2007

rn patients born before rubella vaccinations (1919-1958) the percentages of FHI and two other eye inflammatory diseases were about equal. But there was a 69 percent drop in FHI in patients born the following decade (1959-1968) and a further 40 percent drop in patients born from 1969 to 1978. Only one FHI patient born during the decade 1979-1988 was seen.

Over the same periods, the percentage of foreign-born patients with FHI increased compared with the controls.

Rubella vaccination was implemented in the United States in 1969. By 1977, an estimated 60 percent of children had been vaccinated, with an 80 percent decline in cases.

Currently, children commonly receive two doses of the vaccine by the time they are six years old. As a result of the vaccination program, the majority of U.S. rubella cases now occur in foreign-born individuals.

The vast majority of eye inflammatory diseases have no known cause, according to Goldstein. "Although this kind of study has its limitations, it's exciting to find convincing epidemiological support for earlier research implicating the rubella virus as a cause of FHI," she said.


'/>"/>

Contact: Jeanne Galatzer-Levy
jgala@uic.edu
312-996-1583
University of Illinois at Chicago
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Focused Treatment For Childhood Cancer
2. Osteoporosis associated with Childhood Cancer
3. Stroke also in list of common childhood ailments
4. Asthma is not just a childhood condition
5. Asthma not just a childhood condition
6. Childhood Sunburn Can Lead to Skin Cancer Later
7. Preventing Childhood Deaths
8. Radiation Not Needed for Childhood Cancers
9. Troubled Childhood found to affect your Liver
10. Elevated LDL levels in Childhood could be Predictors of Heart Disease
11. Persistent Childhood Wheeze Probably Inherited
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...mmune response after antiretroviral therapy may be... 25 (HealthDay News) -- A new study challenges the... impairs the immune system,s ability to restore it...tive antiretroviral therapy (HAART). , From 50 ...re also infected with HCV. Intravenous drug use is...
(Date:7/25/2008)..., July 25 /PRNewswire/ -- BeaconEquity.com announc...ng news today., Investors can view all of the dai...conEquity.com/m , Today,s Trade Alerts include: D...rook Pharmaceuticals Inc. (Nasdaq: MBRK ), NovaMe... ), Affymetrix Inc. (Nasdaq: AFFX ) and,Abaxis In...
(Date:7/25/2008)...Relationship Based on Significant Improvements in ... MDdatacor, Inc., a leader in health,care quality ...s, today,announced it has entered into a long-term...ort Wellmark,s Collaboration on Quality(SM) Incent...tion between Wellmark and,primary care clinicians ...
(Date:7/25/2008)...AD, Calif., July 25 /PRNewswire/ -- AutoGenomics, ...ion statement on Form S-1 with the,Securities and ...al public,offering of shares of its common stock. ..., all of which are expected to be offered by,AutoG...g, have not yet been,determined., J.P. Morgan Sec...
Breaking Medicine News(10 mins):Health News:Study Disproves Belief That Hepatitis C Blunts HIV Drugs 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3Health News:AutoGenomics, Inc. Files Registration Statement for Initial Public Offering 2
...ios Spanos was shocked when his doctor discovered ... his body’s largest blood vessel, the aorta, durin...o symptoms, and was relieved to find out that the ...had been caught while it was still small. For the...
... A brewery in Japan launched production of unusual...farmer who was looking for ways to put his milk su...k will be available in the store shelves Thursday,...akashibetsu, on the country's northernmost island ...
... are planning to whiten your teeth by bleaching th...it done by unqualified people could cause consider...alons are offering teeth whitening by unqualified ...l bleach," said Christopher Orr, president of the ...
...tors and nurses who work in the developing world w...challenges, according to ‘Meeting the Health needs... The BMA’s International Committee surveyed 79 UK...including 67 doctors, who had recently worked in A...
Other Medicine News:Health News:Early Detection of Artery Weakening Can Be a Life-Saver 2Health News:Early Detection of Artery Weakening Can Be a Life-Saver 3Health News:Health Workers Need Better Preparation for Developing World 2
(Date:7/22/2008)...test awards under Therapeutics Development Initiat...tions to 23; next deadline January 20,2009, NEW ...f its mission to,speed delivery of transformative ... Michael J. Fox Foundation for Parkinson,s Researc... industry research teams. The awards,were granted ...
(Date:7/22/2008)... Regimens Including Lantus(R) and Apidra(R) Result...ith Type 2 Diabetes, Whatever the Algorithm ...., July 22 /- Results from the "Adjus...mple Algorithm to Carbohydrate,Counting for Adjust...blished in the American Diabetes Association,s (AD...
(Date:7/22/2008)...eveloped and Validated by Columbia University Medi...oprietary MicroRNA Technology, The Test Differen...ung Cancer (NSCLC), Classifying Squamous-Cell Car...ercent and Specificity of 90 Percent,This is the F... Sensitivity as Biomarkers for Accurate D...
(Date:7/22/2008)...lot Study Suggests That Ekkyo,s New Approach of LA...ly Improve Scar Healing Physiology, MARSEILLES, F...wn as,Heatwave Technology) a photomedicine company...s for skin scar prevention and reduction, announce... Lasers in Surgery and Medicine*,reporting the res...
Breaking Medicine Technology:Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine" 2Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine" 3Avantium and BP Extend Strategic Partnership 3782 1Avantium and BP Extend Strategic Partnership 3782 2ReBuilder Medical Technologies Inc Announces UK Demand for Safe Molluscum Contagiosum Treatment Leads to Distribution Agreement with UFFE Medical L 3779 1ReBuilder Medical Technologies Inc Announces UK Demand for Safe Molluscum Contagiosum Treatment Leads to Distribution Agreement with UFFE Medical L 3779 2ReBuilder Medical Technologies Inc Announces UK Demand for Safe Molluscum Contagiosum Treatment Leads to Distribution Agreement with UFFE Medical L 3779 3Compendia Bioscience Announces the Release and Availability of Oncomine 28TM 29 Research Premium Edition 1289 1Compendia Bioscience Announces the Release and Availability of Oncomine 28TM 29 Research Premium Edition 1289 2Pioneer in Reproductive Medicine Opens The Countrys First Comprehensive Fertility Practice 1286 1Pioneer in Reproductive Medicine Opens The Countrys First Comprehensive Fertility Practice 1286 2
...s Efficacy at Improving Glycemic Control and,Reduc..., Ill., June 23, 2007 /PRNewswire/ -- VeroScience,...rtner S2 Therapeutics,Inc., reported today the re...the overall and cardiovascular safety of Cycloset(...mesylate) in subjects,with type 2 diabetes. The st...
...--Jun 25, 2007 - HepaLife Technologies, Inc.,(OTCB...that new,data presented at an international influe...,s patented PBS-1 cell line outperforms,current ce...us,inside its cells. The most important step towar...against a targeted virus is the,ability to efficie...
Other Medicine Technology:Phase IIIb Clinical Data Validate the Overall and Cardiovascular,Safety Profile of Cycloset (A Quick Release Formulation of,Bromocriptine Mesylate) in Patients with Type 2 Diabetes 2Phase IIIb Clinical Data Validate the Overall and Cardiovascular,Safety Profile of Cycloset (A Quick Release Formulation of,Bromocriptine Mesylate) in Patients with Type 2 Diabetes 3Phase IIIb Clinical Data Validate the Overall and Cardiovascular,Safety Profile of Cycloset (A Quick Release Formulation of,Bromocriptine Mesylate) in Patients with Type 2 Diabetes 4Phase IIIb Clinical Data Validate the Overall and Cardiovascular,Safety Profile of Cycloset (A Quick Release Formulation of,Bromocriptine Mesylate) in Patients with Type 2 Diabetes 5HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 2HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 3HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 4HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 5HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 6
...y Biotech Captia™ Varicella- Zoster Virus (VZV...s intended for the detection and quantitative dete...dividual serum specimens may be used for the deter...convalescent, may be used to demonstrate seroconve...
The DSL-05-10-VZM Varicella Zoster IgM Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgM-class antibodies to Varicella Zoster Virus in human serum. This as
The Trinity Biotech Mumps IgM Enzyme-Linked Immunosorbent Assay (ELISA) is intended for the qualitative detection of IgM antibody in human serum to Mumps for the determination of immunological experi
The DIAGNOSTIC AUTOMATION, INC. (DAI) Mumps IgG Enzyme-Linked Immunosorbent Assay (ELISA) is intended for the detection and quantitative determination of IgG antibody to Mumps virus in human sera. In
Medicine Products: